PRQR icon

ProQR Therapeutics
PRQR

Overview Fund Activity

27 hedge funds and large institutions have $37.1M invested in ProQR Therapeutics in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$3.23M
2
AG
2
Artal Group
Luxembourg
$6.13M
3
SM
3
Sabby Management
Florida
$1.12M
4
OPPM
4
Opus Point Partners Management
New York
$992K
5
DCM
5
DAFNA Capital Management
California
$744K

Top Sellers

1
O
1
OrbiMed
New York
$4.2M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
RG
3
Redmile Group
California
$5.03M
4
PCM
4
Prelude Capital Management
New York
$0
5
VF
5
Virtu Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$3K – – –
Janus Henderson Group
27
Janus Henderson Group
United Kingdom
– -$690K -142,350 Closed
PCM
28
Prelude Capital Management
New York
– -$71K -14,700 Closed
VF
29
Virtu Financial
New York
– -$64K -13,150 Closed
Geode Capital Management
30
Geode Capital Management
Massachusetts
– -$59K -12,211 Closed
Deutsche Bank
31
Deutsche Bank
Germany
– -$46K -9,500 Closed
TDC
32
Thompson Davis & Co
Virginia
– -$10K -2,000 Closed
1
2